Chemical Genetic Analysis of RAS Signaling
- Institution
- University of Washington, WA
- Principal investigator
- Dustin J Maly
- Funding
- $328K
- Duration
- 2022–2026
Moonbase score
Still being scored
Abstract
Abstract The GTPase RAS functions as a molecular “on/off” switch, existing both in GDP-bound (inactive) and GTP- bound forms (active). Despite functioning as a simple binary switch, RAS is capable of directing complex and diverse cellular processes, including proliferation, migration, survival, and T-cell development. Recent work suggests that the ability of RAS to play complex, often conflicting roles in diverse processes results from differences in cellular context and and/or subcellular localization of its signaling. We have developed a novel chemical genetic tool–called Chemically-Inducible Activator of RAS (CIAR)–to study the dynamics of the signaling networks that are mediated by RAS activity. CIAR allows rapid and dose-dependent activation of RAS signaling with a cell permeable small molecule. With CIAR, we propose to use targeted, quantitative phosphoproteomics and transcriptomics to study the fundamental dynamic behavior of RAS-driven signaling. Subcellularly-localized versions of CIAR will also be used to determine the effects of localized RAS activation on the dynamics of RAS-mediated signaling. Finally, we will explore positive and negative feedback within RAS-driven signaling pathways by selectively enhancing or inhibiting downstream signaling components.
LOADING MOONBASE SCORE
Questions for University of Washington
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of WashingtonNot yet scored
Chemical biological analysis of RAF Kinases
Dustin J Maly · $498K · 2024–2029
- NIH · University of WashingtonNot yet scored
New Molecular Probes For Protein Kinases
Dustin J Maly · $328K · 2008–2026
- NIH · University of Washington66
NextGen Long-acting and targeted combination ART for Children with HIV
Rodney J.Y. Ho · $1.4M · 2020–2026